ReiThera vaccine at risk of stop, Corte dei Conti freezes funds

The Italian vaccine ReiThera against Covid at risk of stop. The Court of Auditors has in fact made it known that it has not registered the decree for its production and therefore the biotech of Castel Romano risks not receiving the funds from Invitalia. The control office, writes the accounting magistracy in a note, on 4 May last, “considering that the answers provided by the Administration were not suitable to overcome the observations made in the survey, referred the question to the examination of the Board of the Section central control of legitimacy “. At the conclusion of the meeting, on 11 May 2021, “the Central Section resolved to reject the approval of the decree” relating to the Development Agreement signed on 17 February 2021. “The deed was therefore not admitted to registration “. This was announced by the Court of Auditors.On 1 March 2021 the decree relating to the Development Agreement signed on 17 February 2021 by the Ministry of Economic Development, by Invitalia spa and by the ReiThera srl ​​company was submitted to the preventive check of legitimacy , aimed at supporting the industrial development program to be carried out at the production plant located in Castel Romano. This program consists of a production investment project – aimed at expanding the production plant located in Castel Romano (Rome), and an industrial research and experimental development project, intended to complete the clinical trial (phase 2 and 3) of the anti Covid-19 vaccine. The decree provided for the provision of resources up to a maximum of 50 million euros for the financing of investments, of which 41 million euros as a non-repayable fund and the rest as a subsidized fund (out of a total of 80 million provided for by the so-called The relaunch decree) Following the preliminary investigation, on 8 April 2021, a finding was formulated by the competent Audit Office of the Court. The Administration found this finding, providing the requested clarifications, on April 21, 2021. Subsequently, on May 4, 2021, the Control Office deeming that the answers provided by the Administration were not suitable to overcome the observations made in the survey , has referred the matter to the examination of the Board of the Central Section for legitimacy control. At the conclusion of the meeting, on 11 May 2021, the Central Section resolved to reject the approval of the decree. The deed was therefore not admitted to registration.